(Q43720370)

English

Novel gelatin-adriamycin sustained drug release system for intravesical therapy of bladder cancer

scientific article published in January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Novel gelatin-adriamycin sustained drug release system for intravesical therapy of bladder cancer (English)

1 reference

Europe PubMed Central

26 November 2017

author name string

Ye Z

1

1 reference

Europe PubMed Central

26 November 2017

Chen J

2

1 reference

Europe PubMed Central

26 November 2017

Zhang X

3

1 reference

Europe PubMed Central

26 November 2017

Li J

4

1 reference

Europe PubMed Central

26 November 2017

Zhou S

5

1 reference

Europe PubMed Central

26 November 2017

Yang W

6

1 reference

Europe PubMed Central

26 November 2017

Zhang Y

7

1 reference

Europe PubMed Central

26 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

26 November 2017

Journal of Tongji Medical University

1 reference

Europe PubMed Central

26 November 2017

21

1 reference

Europe PubMed Central

26 November 2017

145-148

1 reference

Europe PubMed Central

26 November 2017

2

1 reference

Europe PubMed Central

26 November 2017

Intravesical adriamycin chemotherapy in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11523222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of carcinoma in situ of the bladder with doxorubicin (adriamycin)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11523222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1G3 bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11523222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preparation of multivesicular liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11523222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled release of biologically active compounds from bioerodible polymers

1 reference

https://pubmed.ncbi.nlm.nih.gov/11523222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11523222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11523222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11523222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02888081

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43720370&oldid=2102822657"